Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Hyatt Regency Tysons Corner

Nov 03, 2022 12:00 PM - Nov 04, 2022 8:20 PM

7901 Tysons One Place, Tysons Corner, VA 22102

Innovative Trial Designs Conference

Innovating for Modernized Clinical Trials

Session 4: Innovative Trial Designs with Information Borrowing Including Basket Trials

Session Chair(s)

Michelle  Detry, PhD

Michelle Detry, PhD

Director, Adaptive Trial Execution & Senior Statistical Scientist

Berry Consultants LLC, United States

Yi  Liu, PhD

Yi Liu, PhD

Vice President, Biometrics

Nektar Therapeutics, United States

This session will highlight innovations in clinical trial design where information is borrowed or shared in the primary trial analyses. Examples will include sharing of information from within a trial, e.g. Basket Trials, or borrowing of information external to the trial. The use of information borrowing in trial design requires thoughtful consideration not only regarding which information that is shared or borrowed and the amount of borrowing, but also the statistical adjustments that need to be considered to ensure trial results are scientifically valid and accepted by the scientific community and regulatory authorities. Case studies with information borrowing or sharing, both internal and external to a trial, will be presented.

Learning Objective :
  • Outline why information borrowing may be considered and included in trial designs and the resulting potential benefits/efficiencies towards answering the trial question
  • Describe considerations and statistical adjustments that need to be implemented when borrowing of information is included in a trial design
  • Identify multiple clinical trial designs where information borrowing through internal sharing, or external borrowing, was a key design component

Speaker(s)

Robert A. Beckman, MD

Utilizing Real-World Data (RWD) to Inform a Confirmatory Basket Trial (CBT) Design: Studying Use of Rituximab in Autoimmune Diseases

Robert A. Beckman, MD

Georgetown University Medical Center, United States

Professor of Oncology and of Biostatistics, Bioinformatics, and Biomathematics

Joe  Marion, PhD

Borrowing Phase 2 Data in Phase 3: The PUNCH CD3 Trial

Joe Marion, PhD

Berry Consultants, United States

Senior Statistical Scientist

Dieter Adrian Haering, DrSc, PhD

NEOS: An Innovative Bayesian Non-inferiority Trial Design in Pediatric Multiple Sclerosis

Dieter Adrian Haering, DrSc, PhD

Novartis, Switzerland

Senior Director Biostatistics

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.